Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
Takahiro Kuno, Visiting Researcher at The University of Tokyo Hospital, Cardiologist and PhD Candidate at Gunma University Hospital, shared a post on LinkedIn:
“A bit delayed, but I had the privilege of attending ACC.26 in New Orleans last month.
I presented our analysis from the COMMAND VTE Registry-2 examining management and outcomes of venous thromboembolism (VTE) across renal function and hemodialysis status.
A key takeaway: bleeding risk in VTE patients is not driven by eGFR alone—being on hemodialysis itself confers additional bleeding risk, beyond what renal function metrics capture.
This nuance matters when we counsel patients on anticoagulation strategy.
It was also my first time in New Orleans, and the jazz culture was a wonderful surprise.
I’d love to go back.
Grateful to all collaborators in the COMMAND VTE Registry-2 investigators group, and to my mentors for their guidance.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience